Poly(<scp>d</scp>,<scp>l</scp>-lactic acid)-block-poly(N-(2-hydroxypropyl)methacrylamide) nanoparticles for overcoming accelerated blood clearance and achieving efficient anti-tumor therapy

Abstract

The substitution of PEG with PHPMA maintained the long circulation of PDLLA-<italic>b</italic>-PEG and alleviated the accelerated blood clearance (ABC).